Sort
82,697 grants matching “vaccine development”
WEILL CORNELL PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,439,199Weill Medical College Of Cornell Univ · U01 · FY2002 · HL
Virus-Host Interactions: Induction and Evasion of Host Innate Immunity
$2,438,675Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa
$2,438,386W. Henry Henry Boom · Case Western Reserve University · R01 · FY2017 · AI
Building mechanistic insight into evolvability of viral cell-entry functions
$2,437,500Tijana Ivanovic · Brandeis University · DP2 · FY2017 · GM
Case Clinical Trials Unit
$2,436,364Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2023 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,435,437Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2014 · AI
Simian Vaccine Evaluation Units
$2,435,221Mark Lewis · Bioqual, Inc. · N01 · FY2012 · AI
Adenovirus-vectored nasal anthrax vaccine
$2,435,173Vaxin Inc. · UC1 · FY2005 · AI
Caribbean Primate Research Center Program
$2,434,892Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2024 · OD
Caribbean Primate Research Center Program
$2,434,892Marcos Lopez · University Of Puerto Rico Med Sciences · P40 · FY2025 · OD
THE IMPACTA PERU CLINICAL TRIALS UNIT
$2,434,595Jorge Luis Sanchez · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2013 · AI
EO-NAT HIV Rapid Point-of-Care Diagnostic Device for Resource-Limited Settings
$2,434,269Ph.d., Daniel Laser · Wave 80 Biosciences, Inc. · N01 · FY2013 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,433,403Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2017 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,433,403Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2015 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,433,401Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2016 · AI
HIV-1 Vaccines Designed to Induce Mucosal Immunity
$2,433,228University Of California Davis · U19 · FY2003 · AI
Integrated Support Services Core
$2,433,051Elke C Muhlberger · Boston University Medical Campus · UC7 · FY2020 · AI
HIV/SIV Data Base and Analysis Unit
$2,431,941Bette Korber · National Institute Of Allergy And Infectious Diseases · Y01 · FY2019 · AI
CD40L adjuvanted clade C DNA and MVA HIV vaccines
$2,431,541Rama Rao Amara · Emory University · U19 · FY2016 · AI
Structure based design of antibodies and vaccines
$2,431,508James E Crowe · Vanderbilt University Medical Center · U19 · FY2016 · AI
Microglial IFN-y production is a key defense system to coordinate both innate and T cell-mediated protective immunity in the brain for preventing reactivation of cerebral Toxoplasma infection
$2,431,364Yasuhiro Suzuki · University Of Kentucky · R01 · FY2025 · AI
Optical Technologies and Molecular Imaging for Cervical Neoplasia
$2,431,163Michele Follen · Drexel University · P01 · FY2011 · CA
FMRG: Bio: Enabling Cell-Free Engineering and Biomanufacturing of Bacteriophages as a Universal Platform for Tailorable Bioactive Materials
$2,430,641Vincent Noireaux · University Of Minnesota-Twin Cities · · FY2022 · ENG
Northwestern University Clinical Trial Unit
$2,430,318Robert L. Murphy · Northwestern University At Chicago · U01 · FY2009 · AI
MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESOURCE REPOSITORY (MID-BRR)
$2,430,000James McArdle · American Type Culture Collection · N01 · FY2011 · AI